These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11727711)

  • 1. [Methods of determining and evaluating reversibility of airway obstruction].
    Urban S; Redhammer R
    Bratisl Lek Listy; 2001; 102(1):41-2. PubMed ID: 11727711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and management of chronic obstructive pulmonary disease].
    Sato N; Kanazawa M
    Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Which definition to use when defining reversibility of airway obstruction?].
    Ben Saad H; Ben Attia Saafi R; Rouatbi S; Ben Mdella S; Garrouche A; Hadj Mtir A; Harrabi I; Tabka Z; Zbidi A
    Rev Mal Respir; 2007 Nov; 24(9):1107-15. PubMed ID: 18176387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
    Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
    Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of airway obstruction vs bronchodilatation: do we speak the same language?
    Boros PW; Martusewicz-Boros MM
    COPD; 2012 Jun; 9(3):213-5. PubMed ID: 22475111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of Fractional Exhaled Nitric Oxide after Using a Beta-2 Bronchodilator in the Differential Diagnosis of Bronchial Asthma and Chronic Obstructive Pulmonary Disease].
    Ura M; Tanaka H; Takahashi K; Yamazaki H; Fujimoto K
    Rinsho Byori; 2016 Feb; 64(2):127-32. PubMed ID: 27311275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.
    Deesomchok A; Webb KA; Forkert L; Lam YM; Ofir D; Jensen D; O'Donnell DE
    COPD; 2010 Dec; 7(6):428-37. PubMed ID: 21166631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
    MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of acute bronchodilator tests in patients with chronic obstructive lung disease and bronchial asthma].
    Vizel' AA; Vizel' IIu; Vizel' EA
    Probl Tuberk Bolezn Legk; 2005; (7):40-4. PubMed ID: 16130428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic airways obstruction in pulmonary sarcoidosis: its poor response to bronchodilators.
    Young RC; Sahetya GK; Hassan SN; Cobb WB; Kumar B; Facen HT
    J Natl Med Assoc; 1980 Oct; 72(10):965-72. PubMed ID: 7420439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution CT and bronchial reversibility test for diagnosing COPD.
    Kurashima K; Takayanagi N; Sato N; Kanauchi T; Hoshi T; Tokunaga D; Ubukata M; Yanagisawa T; Sugita Y; Kanazawa M
    Respirology; 2005 Jun; 10(3):316-22. PubMed ID: 15955144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations.
    Calverley PM; Albert P; Walker PP
    Lancet Respir Med; 2013 Sep; 1(7):564-73. PubMed ID: 24461617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD).
    Costantini AM; Sallustio G; Misciasci T; Corbo GM; Valente S; Pirronti T; Marano P
    Radiol Med; 2004; 108(1-2):17-27. PubMed ID: 15269687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchodilators--effective also in negative broncholysis test. Decreased dyspnea decreased in any case].
    Vogelmeier C
    MMW Fortschr Med; 2002 Apr; 144(15):34-6, 38. PubMed ID: 12004447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future of chronic obstructive pulmonary disease management.
    D'Urzo A; Vogelmeier C
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant bronchodilator responsiveness and "reversibility" in a population sample.
    Prentice HA; Mannino DM; Caldwell GG; Bush HM
    COPD; 2010 Oct; 7(5):323-30. PubMed ID: 20854046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator.
    Enright P; Quanjer P
    COPD; 2007 Jun; 4(2):89-90. PubMed ID: 17530501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.